Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place
Save the Date!

Click here for the full Medical Affairs Agenda.
Your Barcelona pass gives you access to both meetings.

Agenda

Day 1 (13 March)

Registration – 7:00am
Start – 8:40am
Finish – 6:25pm
Networking drinks till 8pm

Day 2 (14 March)

Start - 8:50am
Finish – 5:50pm
Networking drinks till 7:30pm

Day 3 (15 March)

Start - 9am
Finish - 1:10pm
Seated lunch till 3pm

Keynotes
08:40 - 08:50
Chairman Opening

eyeforpharma Paul Simms Chairman eyeforpharma

08:50 - 09:15
Redefining our role in a Volatile, Uncertain, Complex and Ambiguous (VUCA) world
  • Identify the challenges pharma must overcome in this world of unpredictable social, economic and political change
  • Be the solution: redefine the role we play in the healthcare eco-system and come together to build the solutions that truly meet the need of patients and care givers
  • Recognise how other industries have been disrupted by unexpected competition and ensure pharma is prepared to face the challenges of tomorrow
  • Explore the world of healthcare from a higher perspective and ensure that we are at the core of the discussion on the shape of its future

Janssen Kris Sterkens Company Group Chairman Europe, Middle East, and Africa Janssen

09:15 - 09:35
Creating greater value for patients in a shifting innovation paradigm
  • Bayer’s mission “Science For A Better Life” gives us purpose. For us the Pharma business means delivering superior value to all our stakeholders. But it is the patients that matter most.
  • Innovation is crucial in our journey to help patients. We are living in a revolutionary time of scientific change, particularly in medicine.
  • Unfortunately, interest in healthcare does not always equate to interest in better healthcare, as we are often faced with policy approaches targeting medicines’ budgets in isolation for the sake of short-term savings.
  • At the same time, at Bayer we recognize a shift in the innovation paradigm driven by digitization, increasing personalization and a resulting empowerment of the patient in the management of his / her own health. Such changes will give rise to new business models and new forms of value creation.

Bayer Pharmaceuticals Sebastian Guth Executive Vice President and Chief Marketing Officer Bayer Pharmaceuticals

09:35 - 09:55
Make the Future Personal
  • Join Christi in her personal mission to increase survival and quality of life for patients
  • Create new solutions guaranteeing more patents have access to life changing medicines
  • Technology tools is giving patients control and will improve our ability to provide personalized patient therapies
  • A new paradigm: collaboration with multiple stakeholders will be key to accelerating innovation and achieving better patient outcomes
  • Think beyond the medicine to focus on breakthroughs that come closer to a cure, and look towards a more holistic patient journey

Lilly Bio Medicines Christi Shaw Senior Vice President and President Lilly Bio Medicines

09:55 - 10:35
Panel: Futureproof patient access by delivering real value
  • How pharma can continue to deliver innovative medicines and maintain commercial success
  • Define the true value of your medicines and ensure this can be communicated to different stakeholders
  • How will the industry continue to deliver affordable treatments across challenging markets?

AstraZeneca Mark Mallon Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs AstraZeneca

Citi Andrew Baum Managing Director Global Head of Healthcare Research Citi

World Heart Federation Jean-Luc Eiselé CEO World Heart Federation

10:35 - 10:45
Winner announced eyeforpharma Awards - Most Valuable Patient Initiative
10:45 - 11:15
Coffee Break and Networking
11:15 - 11:55
Panel: Be the go-to source: how your company can become the ultimate guide for customers and patients
  • Can a pharma company become a credible hub for medical and product knowledge?
  • How the patient provides an aligning force between stakeholders – and how to use this to forge deeper partnerships
  • Beyond transparency: ideas for restoration of our industry’s reputation and regaining stakeholder trust in the information we provide
  • How advances in data capture and analysis can be harnessed to bolster relationships with key stakeholders

MSD Julie Gerberding Executive Vice President & Chief Patient Officer MSD

EFPIA Nathalie Moll Director General EFPIA

Gates Foundation Andrin Oswald Director – Life Sciences Partnerships,Global Health Gates Foundation

Merck Steven Hildemann Global Chief Medical Officer Merck KGaA

11:55 - 12:25
Hitting a smaller target, more often: driving profitable growth in a world of increasingly precise
  • The Pharma industry continues to innovate at an increasingly faster pace, however, this innovation looks different today than it did 20 years ago with transformation from mass-market launches to the world of more targeted and precise medicine
  • A more precise world means new novel treatments in underserved diseases, higher survival rates and better outcomes for the patient and healthcare system
  • For pharma, it means patients and their prescribers are harder to find, competition is more intense and proving value of medicine is much harder.
  • To grow profitably, companies need to be more precise, targeted and efficient in developing and commercialising new innovations which will require leverage of the growing availability of healthcare data, advanced analytics and technology alongside innovations in human science

IQVIA Alistair Grenfell President, Northern Europe, Middle East, Africa and South Africa IQVIA

12:25 - 12:35
Winner announced eyeforpharma Awards - Patient Advocate Award
12:35 - 12:55
Beyond Producing Medicines: Advancing Access to Care is Part of Our Promise
  • Access is an Imperative, Not an Afterthought - understand how to steer this mindset across the whole organization
  • Patient Focus & Engagement are Critical - learn how to master this imperative in changing environments and among differing market trends
  • Proving Value Includes Quantifying It – how to focus on outcomes

CSL Limited Paul Perreault CEO CSL Limited

12:55 - 14:15
Lunch & Networking Session
Commercial Model Innovation Track
Learning and Development Track
Enhanced Patient Solutions Track
14:15 - 14:20
Chairman Opening

RxLogix Corporation Raj More Chief Architect & CEO RxLogix Corporation

Chairman Opening

PEGA Ed Chase Senior Director, Life Sciences Strategy PEGA

Chairman Opening

mavens Louise Gargan European Sales Director Mavens

14:20 - 14:45
What’s pharma’s next play? Disrupting the traditional model to guarantee a place in tomorrow’s world

Sanofi Colin Sims SVP, Head, Transversal Corporate Strategy Sanofi

A complete guide commercial success: How Almirall put the theory into practice

Almirall Carlos Sosa Director Global Sales Operations Excellence Almirall

Improving Health: Teva’s united vision for improved patient support
  • Gain expert advice on how to partner with patient groups and ensure the patient voice is heard throughout your organisations
  • Understand how pharma can collectively support patients throughout the healthcare system through Teva’s Improving Health initiative
  • Hear how Teva’s new issue focussed framework if being taken forward and see the progress made

TEVA Ruth Wilson Global Head of Patient Advocacy TEVA

14:45 - 15:15
The rise of multi-stakeholder omni-channel engagement: Patient, Provider, Payer, Partner
  • Speciality and personalised drugs require more patient-focussed attention while tendering and pricing require stronger managed markets and key account functions
  • The need for coordinated care, RWE, HEOR and new entrants to the healthcare ecosystem are challenging established roles, leading to new models of collaboration
  • Understand how all stakeholders benefit from one integrated ecosystem: leveraging all channels and simultaneously allowing to manage better journeys with patients, providers, payers and partners

Salesforce Dr. Wolfgang Lippert Senior Director, Head of Healthcare & Life Sciences EMEA Salesforce

Session announced next week
Now, near and next: Pharma’s role in technology enhanced patient support services
  • Discover the driving force behind pharma developing services beyond traditional patient support programs
  • Identify the key characteristics of best-in-class support programs - what works and what doesn’t?
  • Visualise the immense possibilities opened-up by technology and discuss how far pharma should venture

S3 Connected Health Jim O'Donoghue Vice President S3 Connected Health

15:15 - 16:20
Workshop Sessions

The workshops are for pharma & biotech companies only. Coffee and snacks will be served in the expo hall at this time


16:20 - 16:50
Coffee Break & Networking Sessions
16:50 - 17:20
Time to go WAY "beyond the pill" with Augmented Intelligence

IBM Watson Health Christina Busmalis Director IBM Watson Health, Global Life Sciences

Session announced next week
Patient-Centric Clinical Trials: The First Step Toward Improved Patient Solutions
  • Involve patients, caregivers and advocates to ensure trial design resonates with the targeted population
  • Use patient input to optimize trial operations, improving both recruitment and retention
  • Identify best practices for patient engagement from phase 2 to phase 4 and beyond

ICON plc Kelly Franchetti, RN CCRN CEN VP, Patient Insights and Engagement, Commercialisation & Outcomes ICON plc

17:20 - 17:45
The generic difference: generating competitive advantages in difficult environments

Actavis Petr Kozel Vice President Sales and Marketing Actavis

Building capabilities, talent and organizational readiness from within (Two Case Studies): How to change tires on a moving car
  • Gain competitive advantage for long-term commercial changes by evolving both the front- and back-end of operations
  • Operationalize personalized large-scale Field Force training to upskill commercial workforce while identifying your best performers of tomorrow
  • Use your most transactional processes to give yourself the agility to adapt and anticipate changing strategic business priorities

Pfizer Emilie Bugeat Senior Director Commercial Operations Pfizer

Patients First: a guide and an inspiration
  • As market and technology forces move the pharmaceutical industry towards patients, competing interests and system complexities risk losing them in the shuffle
  • If the pharmaceutical industry and national governments only debate with one another, they risk disconnecting with patients
  • The conversation needs to change in order to cut through the news and the noise and to put innovation for patients at the heart of it

Pfizer Internal Medicine Beatriz Faro Regional President, International Developed Markets Pfizer Internal Medicine

17:45 - 18:25
Panel: Embrace Patient Centricity as your Key Commercial Focus
  • Establish the relationship between business growth and patient focus, reaffirming belief in your company that it’s the right thing to do for business and patient
  • Explore metrics to reveal the commercial impact of patient-centric initiatives, including performance indicators that can guide your line management
  • Expand your business offering to truly service patients and the provide support needed for HCPs to deliver the full potential of your product

CSL Behring Lutz Bonacker SVP and General Manager, Commercial Operations Europe CSL Behring

Grünenthal Group Lars Joensson Lead Patient Engagement Grünenthal Group

Shire Thomas Kerscher Global Head Patient and Customer Excellence Shire

OSG Dr R. Sukumar CEO OSG

Moderator: Ipsos Healthcare Victoria Guyatt Head of Ethnography Ipsos Healthcare

Panel: Pharma’s future leadership: why diversity is shaping the future of our industry
  • Take a fresh look at the qualities required to take pharma companies forward in tomorrow’s environment
  • Where diversity works – examples of how leadership from women and ethnic minorities has created real advantage across pharma and other industries
  • Discover how the new qualities required for high-performance leadership are affecting how companies nurture talent for the long-term

Roche Diabetes Care Lisa Huse General Manager, Spain Roche Diabetes Care

Lilly Bio Medicines Christi Shaw President and SVP Lilly Bio Medicines

Pfizer Nolan Townsend Regional President, International Developed Markets Pfizer

Moderator: HBA Laurie Cooke CEO HBA

Panel: Rebuild your reputation – how to become patient organisations number one partner
  • Address the fundamental issues around patient engagement and encourage advocacy groups work closely to provide feedback throughout your product lifecycle
  • Understand why long-term partnerships can provide positive results for your business and improve patient outcomes
  • Reinvent pharma in the eyes of the public, further encouraging more collaborations and encouraging more enthusiastic, passionate and talented people into the industry

Shire Miguel Bernebeu Global Head of Market Access, Pricing and Health Economics Shire

AbbVie Amy Nicole Nayar Head Of Global Patient Relations AbbVie

EUFAMI Margaret Walker Executive Director EUFAMI

Markus Leyck Dieken Former SVP - Global Head of CNS TEVA

18:25 - 20:00
Networking Drinks Reception
Advances in Customer Engagement Track
Digital Innovation And Analytics Track
Patient Innovation Track
08:50 - 09:00
Chairman Opening

Bionical Bionical

Chairman Opening

Kanga Health Kay Wesley Chief Executive Kanga Health

Chairman Opening

Bionical Bionical

09:00 - 09:30
In constant pursuit of ‘better’: How Google is utilising AI to make genuine healthcare breakthroughs
  • Discover how AI and machine learning are impacting everything we do – from the big to the small
  • Successfully implement the change needed to constantly improve productivity and leverage data to make smarter decisions
  • Recognise new insights from Google and Verily and understand how they’re leading to vast improvements helping sufferers of depression

Google Ryan Olohan Managing Director Healthcare Google

Accelerate innovation by addressing patient and company challenges with design thinking:
  • Learn how aspects of design thinking can be applied to generate solutions and solve even the most complex problems in the healthcare environment,
  • Think beyond digital, ensuring your organisation utilises new technology and ways of thinking to enhance the patient journey.
  • Envisage how other industries and companies have embedded design thinking within their organisation, which allows for continuous feedback and improvements to products and services

UCB Gregory Miller VP & Global Head Innovation Acceleration CoE UCB

Roundtables: Revolutionise support through digital and new tech

In an age where everyone is glued to their smartphone, and the world wide web is never more than a quick click away, patients can play a larger role in their own healthcare. So, are wearable devices, smart contact lenses and detailed mobile apps the answer to all healthcare’s issues? Maybe…but first we must create usable tools which genuinely benefit patients’ lives.

  • Visualise how new technology is empowering patients to take a more active role in monitoring their health and treatments
  • Understand how patients and HCPs envisage using digital tools and devices, ensuring your services around the pill provide real benefit and improve lives
  • Co-create new tools to ensure simple and effective user experience, and collect continuous feedback to further improve functionality and performance

ECCO – the European CanCer Organisation Birgit Beger Chief Executive Officer ECCO – the European CanCer Organisation

- Teresa Ferreiro Certified Professional Co-active Coach (CPCC) (ACC)

Shire Miguel Bernebeu Global Head of Market Access, Pricing and Health Economics Shire

Carole Sian Scrafton MBS, BA (hons) Patient Advocate

Sonia Hawkins Patient Advocate

Barcelona Children’s Hospital Begonya Nafría Patient Advocacy Manager Barcelona Children’s Hospital

MSD Sinead Tuite Patient Programmes Manager, Immunology MSD

Myeloma UK Rosemarie Finley Chief Executive Myeloma UK

Astrid Wijngaarden Patient Advocate

The Epilepsy Society Jasmine Smith Patient Ambassador The Epilepsy Society

09:30 - 10:00
Now its personal: Using machine learning to personalize your future customer centric strategy
  • As streams of customer information are rapidly expanding to ‘big data lakes’, this talk will learn you how to use these great sources to develop a deeper understanding about the individual needs and wants of customers
  • Discover how AI and machine learning can help pharma companies to maximize this data potential and support better decision making
  • Find out how a customer centric strategy can be enriched by an unrivalled personalised touch

Trilations Björn Van Loy (PhD) Competence Centre Lead Advanced Analytics Trilations

Using Machine Learning to Develop Winning Digital Channel Strategy, Execution and Analysis

IQVIA Bernd Haas Vice President, Technology Solutions IQVIA

IQVIA Agnieszka Wolk Director, Statistical Services IQVIA

10:00-10:40
Panel: Slick, seamless, yet sophisticated: delivering the ultimate customer experience
  • Envision how pharma can learn from industries who’ve created  truly integrated multichannel offering and seamlessly blend user experience across all channels
  • Equip different departments to begin the CX transition and ensure the required capabilities are in place to optimise mobile and digital channels
  • Tailor your marketing strategy to ensure alignment between various platforms to ensure a seamless, consistent and effortless user experience

Biogen Tommy Kok Annfeldt Senior Manager Digital 3rd Party Media and Innovation EU and Canada Biogen

Grünenthal Group Florent Edouard SVP, Global Head of Commercial Excellence and Customer Engagement Grünenthal Group

TEVA Davidek Herron Head of Human Channels, Customer Experience TEVA

Panel: The evolving needs of the digital native customer
  • Hear directly from patients and caregivers to identify their needs and tailor future communication
  • Remove the guesswork: build a comprehensive understanding of how to communicate with your customers, tailor your content and ensure consistent messaging across channels
  • Identify opportunities to support HCP-patient relationships, improving outcomes and cementing your company as a trusted partner

Pharmaceuticals ALK Mads Lacoppidan General Manager & Head of Consumer Division Pharmaceuticals ALK

- Teresa Ferreiro Certified Professional Co-active Coach (CPCC) (ACC)

TEVA Mark Milton Edwards Global Commercial Senior Director TEVA

SERMAS - Madrilenian Health Service Javier Rodríguez Hernández Medical Director Hospital La Fuenfría SERMAS-Madrilenian Health Service

Session announced next week

Merck Steven Hildemann Global Chief Medical Officer Merck

10:40 - 11:10
Coffee Break & Networking Sessions
11:10 - 11:40
Reinvent your go-to-market model: the integrated multichannel approach
  • Discover how Pfizer Oncology recently delivered a series successful product launches by evolving their go-to market approach
  • Evolve the traditional sales force model to deliver an improved integrated multichannel experience, utilising new digital channels and capabilities
  • Identify key markets to develop pilots and tailor to successfully role out across your whole organisation

Pfizer Markus Kosch Vice President Oncology Portfolio, Europe, Japan & Developed Asia Pfizer

Innovation for a bright future- Time to deliver genuine results from innovation and tech
  • Create a shift in the mindset of your commercial teams which encourages adaption of new ways of working and future-proofs your organisation
  • Ensure innovation strategy is a fusion of the best and brightest in science and technology
  • Case Study: Understand how Merck Biopharma is leading the future with the Innovation Cup – Cross-generational innovation to cover unmet medical need

Merck Biopharma Ulrich Betz Vice President Innovation Merck Biopharma

How R&D at Grünenthal is being shaped by listening to patients with chronic pain conditions

Grünenthal Group Lars Joensson Lead Patient Engagement Grünenthal Group

11:40 - 12:10
Artificial Irrelevance: Do physicians actually care about Healthcare’s AI Revolution?
  • “Artificial Intelligence” is the biggest buzzword in our industry, just like “Wearables” and “Mobile Apps” before it. How do we separate the fluff from meaningful new opportunities in physician engagement?
  • In this talk, Medscape’s VP of Product Design and Innovation takes a close look at global physician attitudes and behaviours to help marketers form innovative strategies for effective program design

Medscape/Web MD Ben Greenberg Vice President of Product and User Experience WebMD/ Medscape

Session announced next week
People versus study subjects and data points: Why we need to rethink patient engagement across the clinical development and commercial lifecycle

IQVIA John Procter Head of Global Service & Solution Development Patient Engagement & Medical Affairs IQVIA

12:10 - 13:15
Workshop Sessions

The workshops are for pharma & biotech companies only. Coffee and snacks will be served in the expo hall at this time


13:15 - 14:15
Lunch & Networking Session
Advances in Customer Engagement Track
Commercial Model Innovation Track
Patient Innovation Track
14:15 - 14:20
Chairman Opening

Bionical Bionical

Chairman Opening

Eagle Productivity Solutions Eagle Productivity Solutions

Chairman Opening

Bionical Bionical

14:20 - 14:50
Patients as your most insightful colleague
  • Learn from the experts - move past the lip-service and instil genuine patient insight into your business planning
  • Ensure your brand differentiates itself in a crowded market by guaranteeing your product offerings deliver real benefit to patients
  • Set up regular touch points with end users to ensure you don’t lose sight of initial goals and traditional working methods do not prevent genuine breakthroughs

Pfizer Nolan Townsend Regional President, International Developed Markets Pfizer

Generate competitive advantages through creative commercialisation strategies: lessons learned from oncology biosimilars
  • Identify innovative ways to market your product and portfolio in a highly competitive biosimilar market
  • Leveraging learnings from the Oncology Biosimilar market to successful commercialization approaches within the oncology innovator landscape
  • Build a creative CX strategy which truly addresses customer needs and promotes a patient-centric culture within your organization

Boehringer Ingelheim Georgina Rizik Global Commercial Head (Team Leader) of Oncology Biosimilars Franchise Boehringer Ingelheim

Case Study: TEVA Connected Respiratory (incl. CareTRx), on simplifying chronic respiratory diseases management
  • Find out how TEVA is revolutionising chronic respiratory disease management through automatic tracking and adherence tools
  • Listen to how personalised feedback can help patients gain better insight into their condition and achieve their goals
  • The aim: to empower patients to take a more active role in their treatment.

TEVA Pharmaceuticals Mark Milton-Edwards Global Commercial Senior Director TEVA

14:50 - 15:20
Address the biggest challenges in the global HCP community - 4 doctors, 4 countries, 4 specialties
  • Discover key insight from doctors from across a range of locations and specialties
  • Identify biggest challenges currently facing HCPs and how pharma can provide holistic solutions
  • How pharma can utilise digital to improve communication and outcomes for doctors and patients

M3 Paul Rice Chief Operating Officer M3

Cambridge University Hospitals NHSFT Dr Deepak Jadon Consultant Rheumatologist & Director of the Rheumatology Research Unit Cambridge University Hospitals NHSFT

Dr Michael Bangemann HCP

From engagement to outcomes – delivering value with patient programs
  • Understand the key elements of patient engagement strategies that drive both health and business outcomes
  • Realise the balance of technology vs. human elements in patient engagement programs, and how this is driving new opportunities and more successful programs
  • Discover unique insights from a “how-to” story around a real-world example of patient engagement that drives outcomes while enabling automation and scale

PEGA Ed Chase Senior Director, Life Sciences Strategy PEGA

Roundtables: Creating a truly effective patient support program

We all know that advances in digital technology are providing seemingly infinite opportunities to enhance healthcare for patients, but how can we create truly effective solutions? As with most things, it’s critical to start with the end user in mind -- in this instance, the patient. In this interactive session, we’ll explore the building blocks of a successful patient support program, including how to:

  • Use a value proposition framework as a model to identify patient and stakeholder challenges
  • Overcome key challenges that have the greatest impact on health outcomes
  • Discover how to use a MVP (minimum viable product) approach to digital health program development

ECCO – the European CanCer Organisation Birgit Beger Chief Executive Officer ECCO – the European CanCer Organisation

- Teresa Ferreiro Certified Professional Co-active Coach (CPCC) (ACC)

Shire Miguel Bernebeu Global Head of Market Access, Pricing and Health Economics Shire

Carole Sian Scrafton MBS, BA (hons) Patient Advocate

Barcelona Children’s Hospital Joana Claverol Clinical Research Unit Manager Barcelona Children’s Hospital

TEVA Ana Maria Arboleda Director Operations Patient Services Europe TEVA

TEVA Ruth Wilson Global Head of Patient Advocacy TEVA

SERMAS-Madrilenian Health Service Javier Rodríguez Hernández Medical Director Hospital La Fuenfría SERMAS-Madrilenian Health Service

The Epilepsy Society Jasmine Smith Patient Ambassador The Epilepsy Society

15:20 - 15:50
Get personal with a complete 360-degree view of your customer
  • Coordinate a seamless customer experience by delivering complete visibility of all customer interactions across your commercial teams
  • Identify customer trends, learn what works and create a personalised engagement strategy through analysing integrated CRM data across all platforms
  • Understand why even where we purse customer centricity, pharma is not being recognised for being so.
  • Optimise marketing spend by removing wasteful campaigns and engage with customers on their terms

Roche Rafael Ramon Commercial Excellence Leader EEMEA Roche

Session announced next week
15:50 - 16:20
Coffee Break & Networking Sessions
16:20 - 16:50
Measuring pharma performance of the practical application of Lean & Six Sigma methodology: The way to the Customer Engagement

Alfasigma Domenico Zilioli Commercial Director, Spanish Headquarters Alfasigma

Tackle complexity in healthcare head-on: KAM and MSL coordination, Daiichi Sankyo’s ‘Account Engine Model’
  • Create a deeper understanding of your customer network by transitioning to a Key Account Management (KAM) approach
  • Key Account Management (KAM) vs Key Account Organisation (KAO) – evolution of your operating model
  • ‘The Account Engine Model’: Learn how Daiichi Sankyo has developed a new and innovative KAM approach across the territory account teams
  • Develop trusted partnerships which ensure long-term commercial success by addressing needs of prescribers, policy makers, patients and payers
  • Coordinate medical and sales teams to support customers with precise medical information while providing a harmonious customer experience

Daiichi Sankyo Oncology Europe Patrik Grandits Head of Commercial Operations Oncology Europe Daiichi Sankyo Oncology Europe

Social Media 2.0 – empowering patients and families in the management of rare disease
  • Envision how social media can be a powerful tool for educating and supporting, effectively sidestepping geographical and language barriers
  • Develop a user friendly platform with allows for interaction from patients, caregivers, and healthcare professionals
  • See how social media can be used to collect consensual clinical smart data, vastly improving knowledge of disease history, diagnosis, complications and management

Barcelona Children’s Hospital Begonya Nafría Patient Advocacy Manager Barcelona Children’s Hospital

Barcelona Children’s Hospital Joana Claverol Clinical Research Unit Manager Barcelona Children’s Hospital

16:50 - 17:20
Changing the game in customer engagement: New strategies for connection, intelligence and orchestration

IQVIA Kris Bruynseels Senior Principal, Technology Solutions IQVIA

IQVIA Siva Nadarajah General Manager, Social IQVIA

Guarantee success through digital relationship marketing
  • Reignite the relationship: discover why the relationship building is a critical ingredient in effective digital communication
  • Discover how you can effectively access HCPs through digital channels and leverage your existing relationships
  • Improve every aspect of your operations using cutting-edge digital relationship marketing

Connectmedica Michal Komorniczak Global Sales Director Connectmedica

Connectmedica Igor Gnot Partner & CEO Connectmedica

Roundtables: Creating personalised and engaging patient support programs

A new generation of patient support programs are completely reinventing the way patients manage their treatment and engage with pharma. Personalising your value beyond the pill offering as well as recognising unmet needs can help you provide real value to patients. So with so many companies providing these services how can you identify the best place to invest recourses?

  • Personalise individual support programs by carefully tailoring channels, message content and frequency of interactions
  • Combine patient feedback with data to support decision making, clear obstacles and make your patient-focussed decisions more reliable
  • Define metrics which determines success of program, captures both patient and HCP-related outcomes and provides insights to further improve support

ECCO – the European CanCer Organisation Birgit Beger Chief Executive Officer ECCO – the European CanCer Organisation

- Teresa Ferreiro Certified Professional Co-active Coach (CPCC) (ACC)

Shire Miguel Bernebeu Global Head of Market Access, Pricing and Health Economics Shire

17:20 - 17:50
Speak with one voice as an integrated commercial outfit
  • Drive commercial results with full visibility of customer interactions to optimise face-to-face visits
  • Encourage collaboration between marketing and sales departments to allow reps to react to changing preferences in real time
  • Relay customer insights, based on the rep’s knowledge, to personalise future marketing campaigns and tailor outreach

UCB Arnaud Lefevre Head of Operations, Northern Europe UCB

The Biotech revolution in Rare and Orphan diseases? Meet the pioneering companies defining a new commercial model for Pharma
  • Hear about the challenges in terms of market access and reimbursement when payors and regulators are operating in an increasingly cost constrained health system.
  • Understand how these companies; inevitably develop closer, more authentic relationships with patients and why that creates a whole new sense of purpose.
  • Understand the risks and rewards of being part of this Biotech European commercialization revolution.

Moderator: Morgan Prestwich Sean Morgan-Jones VP Global BD Morgan Prestwich

Kyowa Kirin Adrian Steventon-Hill Global Franchise Head Kyowa Kirin

Vertex Pharma Simon Lem VP and General Manager Northern Europe Vertex Pharma

PTC Therapeutics Adrian Haigh SVP & GM EMEA & Asia Pac PTC Therapeutics

Alnylam Pharma Anant Murthy VP Market Access & Policy EU & Canada Alnylam Pharma

17:50 - 19:30
Networking Drinks Reception
Closing Keynote
08:55 - 09:00
Chairman Opening

eyeforpharma Paul Simms Chairman eyeforpharma

09:00 - 09:25
Paving the way for the next generation of fully integrated care
  • Beyond medicine: Develop solutions that can deliver value and real benefits to patients' lives throughout the care continuum
  • Explore partnerships needed to provide holistic care and further support patients: the role that the industry can play
  • Understand the potential of digital in the development of future healthcare models and further possibilities on the horizon

Takeda Giles Platford President, Europe and Canada Business Unit Takeda

09:25 - 09:50
Paradigm shift: From selling drugs to bringing solutions to patients

AstraZeneca Bahija Jallal EVP & Head Medimmune AstraZeneca

09:50 - 10:20
From surviving to thriving: 4 steps to business optimisation
  • Understand why your sales department is the most critical tool for your future positioning and reputation
  • Examine four critical ways to prepare your sales organization for the future.
  • Uncover how to address the disruption in business to fix your sales organization before it’s too late.
  • Identify immediate steps required to improve your performance long-term

Miller Heiman Group Byron Matthews President and CEO Miller Heiman Group

10:20 - 10:30
Winner announced for the eyeforpharma Awards – Most Valuable HCP Initiative
10:30 - 11:10
Panel: The next step in truly integrated healthcare
  • The role of pharma in changing the delivery of healthcare and the partnerships required to solve genuine healthcare challenges
  • Develop a better understanding of the life and treatment with disease to deliver a seamless heathcare solution
  • How the digital revolution and information sharing will develop holistic intergrated care models

Novartis Shreeram Aradhye Chief Medical Officer, Global Head of Medical Affairs Novartis

UICC (Union for International Cancer Control) Dr. Cary Adams CEO UICC (Union for International Cancer Control)

Sanofi Colin Sims SVP, Head, Transversal Corporate Strategy Sanofi

11:10 - 11:40
Coffee Break & Networking Session in the Exhibition Hall
11:40 - 12:05
Session to be announced

Microsoft Microsoft

12:05 - 12:45
Digital Panel: Harness the true power of digital to perform strategic transformations that deliver genuine healthcare innovation
  • The role of digital in improving patient outcomes and commercial results
  • Ensure uptake of digital practices across the entire organisation and embed your digital strategy into the culture
  • The role digital innovations will play in the future of healthcare and how we can get there

Sanofi Milind Kamkolkar Chief Data Officer Sanofi

AstraZeneca Bahija Jallal EVP & Head of Medimmune AstraZeneca

Roche Diabetes Care Jacob Suñol Digital CTO & Digital Ecosystem Roche Diabetes Care

12:45 - 13:00
Winner announced eyeforpharma Awards - Most Valuable Collaboration
13:00 - 13:20
Keynote Address

Almirall Alfredo Barón de Juan EVP Global Commercial Operations Almirall

13:20 - 14:40
Seated Lunch & Networking Session on the 2nd Floor
Keynotes
08:40 - 08:50
Chairman Opening

eyeforpharma Paul Simms Chairman eyeforpharma

08:50 - 09:15
Redefining our role in a Volatile, Uncertain, Complex and Ambiguous (VUCA) world
  • Identify the challenges pharma must overcome in this world of unpredictable social, economic and political change
  • Be the solution: redefine the role we play in the healthcare eco-system and come together to build the solutions that truly meet the need of patients and care givers
  • Recognise how other industries have been disrupted by unexpected competition and ensure pharma is prepared to face the challenges of tomorrow
  • Explore the world of healthcare from a higher perspective and ensure that we are at the core of the discussion on the shape of its future

Janssen Kris Sterkens Company Group Chairman Europe, Middle East, and Africa Janssen

09:15 - 09:35
Creating greater value for patients in a shifting innovation paradigm
  • Bayer’s mission “Science For A Better Life” gives us purpose. For us the Pharma business means delivering superior value to all our stakeholders. But it is the patients that matter most.
  • Innovation is crucial in our journey to help patients. We are living in a revolutionary time of scientific change, particularly in medicine.
  • Unfortunately, interest in healthcare does not always equate to interest in better healthcare, as we are often faced with policy approaches targeting medicines’ budgets in isolation for the sake of short-term savings.
  • At the same time, at Bayer we recognize a shift in the innovation paradigm driven by digitization, increasing personalization and a resulting empowerment of the patient in the management of his / her own health. Such changes will give rise to new business models and new forms of value creation.

Bayer Pharmaceuticals Sebastian Guth Executive Vice President and Chief Marketing Officer Bayer Pharmaceuticals

09:35 - 09:55
Make the Future Personal
  • Join Christi in her personal mission to increase survival and quality of life for patients
  • Create new solutions guaranteeing more patents have access to life changing medicines
  • Technology tools is giving patients control and will improve our ability to provide personalized patient therapies
  • A new paradigm: collaboration with multiple stakeholders will be key to accelerating innovation and achieving better patient outcomes
  • Think beyond the medicine to focus on breakthroughs that come closer to a cure, and look towards a more holistic patient journey

Lilly Bio Medicines Christi Shaw Senior Vice President and President Lilly Bio Medicines

09:55 - 10:35
Panel: Futureproof patient access by delivering real value
  • How pharma can continue to deliver innovative medicines and maintain commercial success
  • Define the true value of your medicines and ensure this can be communicated to different stakeholders
  • How will the industry continue to deliver affordable treatments across challenging markets?

AstraZeneca Mark Mallon Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs AstraZeneca

Citi Andrew Baum Managing Director Global Head of Healthcare Research Citi

World Heart Federation Jean-Luc Eiselé CEO World Heart Federation

10:35 - 10:45
Winner announced eyeforpharma Awards - Most Valuable Patient Initiative
10:45 - 11:15
Coffee Break and Networking
11:15 - 11:55
Panel: Be the go-to source: how your company can become the ultimate guide for customers and patients
  • Can a pharma company become a credible hub for medical and product knowledge?
  • How the patient provides an aligning force between stakeholders – and how to use this to forge deeper partnerships
  • Beyond transparency: ideas for restoration of our industry’s reputation and regaining stakeholder trust in the information we provide
  • How advances in data capture and analysis can be harnessed to bolster relationships with key stakeholders

MSD Julie Gerberding Executive Vice President & Chief Patient Officer MSD

EFPIA Nathalie Moll Director General EFPIA

Gates Foundation Andrin Oswald Director – Life Sciences Partnerships,Global Health Gates Foundation

Merck Steven Hildemann Global Chief Medical Officer Merck KGaA

11:55 - 12:25
Hitting a smaller target, more often: driving profitable growth in a world of increasingly precise
  • The Pharma industry continues to innovate at an increasingly faster pace, however, this innovation looks different today than it did 20 years ago with transformation from mass-market launches to the world of more targeted and precise medicine
  • A more precise world means new novel treatments in underserved diseases, higher survival rates and better outcomes for the patient and healthcare system
  • For pharma, it means patients and their prescribers are harder to find, competition is more intense and proving value of medicine is much harder.
  • To grow profitably, companies need to be more precise, targeted and efficient in developing and commercialising new innovations which will require leverage of the growing availability of healthcare data, advanced analytics and technology alongside innovations in human science

IQVIA Alistair Grenfell President, Northern Europe, Middle East, Africa and South Africa IQVIA

12:25 - 12:35
Winner announced eyeforpharma Awards - Patient Advocate Award
12:35 - 12:55
Beyond Producing Medicines: Advancing Access to Care is Part of Our Promise
  • Access is an Imperative, Not an Afterthought - understand how to steer this mindset across the whole organization
  • Patient Focus & Engagement are Critical - learn how to master this imperative in changing environments and among differing market trends
  • Proving Value Includes Quantifying It – how to focus on outcomes

CSL Limited Paul Perreault CEO CSL Limited

12:55 - 14:15
Lunch & Networking Session
Commercial Model Innovation Track
Learning and Development Track
Enhanced Patient Solutions Track
14:15 - 14:20
Chairman Opening

RxLogix Corporation Raj More Chief Architect & CEO RxLogix Corporation

Chairman Opening

PEGA Ed Chase Senior Director, Life Sciences Strategy PEGA

Chairman Opening

mavens Louise Gargan European Sales Director Mavens

14:20 - 14:45
What’s pharma’s next play? Disrupting the traditional model to guarantee a place in tomorrow’s world

Sanofi Colin Sims SVP, Head, Transversal Corporate Strategy Sanofi

A complete guide commercial success: How Almirall put the theory into practice

Almirall Carlos Sosa Director Global Sales Operations Excellence Almirall

Improving Health: Teva’s united vision for improved patient support
  • Gain expert advice on how to partner with patient groups and ensure the patient voice is heard throughout your organisations
  • Understand how pharma can collectively support patients throughout the healthcare system through Teva’s Improving Health initiative
  • Hear how Teva’s new issue focussed framework if being taken forward and see the progress made

TEVA Ruth Wilson Global Head of Patient Advocacy TEVA

14:45 - 15:15
The rise of multi-stakeholder omni-channel engagement: Patient, Provider, Payer, Partner
  • Speciality and personalised drugs require more patient-focussed attention while tendering and pricing require stronger managed markets and key account functions
  • The need for coordinated care, RWE, HEOR and new entrants to the healthcare ecosystem are challenging established roles, leading to new models of collaboration
  • Understand how all stakeholders benefit from one integrated ecosystem: leveraging all channels and simultaneously allowing to manage better journeys with patients, providers, payers and partners

Salesforce Dr. Wolfgang Lippert Senior Director, Head of Healthcare & Life Sciences EMEA Salesforce

Session announced next week
Now, near and next: Pharma’s role in technology enhanced patient support services
  • Discover the driving force behind pharma developing services beyond traditional patient support programs
  • Identify the key characteristics of best-in-class support programs - what works and what doesn’t?
  • Visualise the immense possibilities opened-up by technology and discuss how far pharma should venture

S3 Connected Health Jim O'Donoghue Vice President S3 Connected Health

15:15 - 16:20
Workshop Sessions

The workshops are for pharma & biotech companies only. Coffee and snacks will be served in the expo hall at this time


16:20 - 16:50
Coffee Break & Networking Sessions
16:50 - 17:20
Time to go WAY "beyond the pill" with Augmented Intelligence

IBM Watson Health Christina Busmalis Director IBM Watson Health, Global Life Sciences

Session announced next week
Patient-Centric Clinical Trials: The First Step Toward Improved Patient Solutions
  • Involve patients, caregivers and advocates to ensure trial design resonates with the targeted population
  • Use patient input to optimize trial operations, improving both recruitment and retention
  • Identify best practices for patient engagement from phase 2 to phase 4 and beyond

ICON plc Kelly Franchetti, RN CCRN CEN VP, Patient Insights and Engagement, Commercialisation & Outcomes ICON plc

17:20 - 17:45
The generic difference: generating competitive advantages in difficult environments

Actavis Petr Kozel Vice President Sales and Marketing Actavis

Building capabilities, talent and organizational readiness from within (Two Case Studies): How to change tires on a moving car
  • Gain competitive advantage for long-term commercial changes by evolving both the front- and back-end of operations
  • Operationalize personalized large-scale Field Force training to upskill commercial workforce while identifying your best performers of tomorrow
  • Use your most transactional processes to give yourself the agility to adapt and anticipate changing strategic business priorities

Pfizer Emilie Bugeat Senior Director Commercial Operations Pfizer

Patients First: a guide and an inspiration
  • As market and technology forces move the pharmaceutical industry towards patients, competing interests and system complexities risk losing them in the shuffle
  • If the pharmaceutical industry and national governments only debate with one another, they risk disconnecting with patients
  • The conversation needs to change in order to cut through the news and the noise and to put innovation for patients at the heart of it

Pfizer Internal Medicine Beatriz Faro Regional President, International Developed Markets Pfizer Internal Medicine

17:45 - 18:25
Panel: Embrace Patient Centricity as your Key Commercial Focus
  • Establish the relationship between business growth and patient focus, reaffirming belief in your company that it’s the right thing to do for business and patient
  • Explore metrics to reveal the commercial impact of patient-centric initiatives, including performance indicators that can guide your line management
  • Expand your business offering to truly service patients and the provide support needed for HCPs to deliver the full potential of your product

CSL Behring Lutz Bonacker SVP and General Manager, Commercial Operations Europe CSL Behring

Grünenthal Group Lars Joensson Lead Patient Engagement Grünenthal Group

Shire Thomas Kerscher Global Head Patient and Customer Excellence Shire

OSG Dr R. Sukumar CEO OSG

Moderator: Ipsos Healthcare Victoria Guyatt Head of Ethnography Ipsos Healthcare

Panel: Pharma’s future leadership: why diversity is shaping the future of our industry
  • Take a fresh look at the qualities required to take pharma companies forward in tomorrow’s environment
  • Where diversity works – examples of how leadership from women and ethnic minorities has created real advantage across pharma and other industries
  • Discover how the new qualities required for high-performance leadership are affecting how companies nurture talent for the long-term

Roche Diabetes Care Lisa Huse General Manager, Spain Roche Diabetes Care

Lilly Bio Medicines Christi Shaw President and SVP Lilly Bio Medicines

Pfizer Nolan Townsend Regional President, International Developed Markets Pfizer

Moderator: HBA Laurie Cooke CEO HBA

Panel: Rebuild your reputation – how to become patient organisations number one partner
  • Address the fundamental issues around patient engagement and encourage advocacy groups work closely to provide feedback throughout your product lifecycle
  • Understand why long-term partnerships can provide positive results for your business and improve patient outcomes
  • Reinvent pharma in the eyes of the public, further encouraging more collaborations and encouraging more enthusiastic, passionate and talented people into the industry

Shire Miguel Bernebeu Global Head of Market Access, Pricing and Health Economics Shire

AbbVie Amy Nicole Nayar Head Of Global Patient Relations AbbVie

EUFAMI Margaret Walker Executive Director EUFAMI

Markus Leyck Dieken Former SVP - Global Head of CNS TEVA

18:25 - 20:00
Networking Drinks Reception

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!

Advances in Customer Engagement Track
Digital Innovation And Analytics Track
Patient Innovation Track
08:50 - 09:00
Chairman Opening

Bionical Bionical

Chairman Opening

Kanga Health Kay Wesley Chief Executive Kanga Health

Chairman Opening

Bionical Bionical

09:00 - 09:30
In constant pursuit of ‘better’: How Google is utilising AI to make genuine healthcare breakthroughs
  • Discover how AI and machine learning are impacting everything we do – from the big to the small
  • Successfully implement the change needed to constantly improve productivity and leverage data to make smarter decisions
  • Recognise new insights from Google and Verily and understand how they’re leading to vast improvements helping sufferers of depression

Google Ryan Olohan Managing Director Healthcare Google

Accelerate innovation by addressing patient and company challenges with design thinking:
  • Learn how aspects of design thinking can be applied to generate solutions and solve even the most complex problems in the healthcare environment,
  • Think beyond digital, ensuring your organisation utilises new technology and ways of thinking to enhance the patient journey.
  • Envisage how other industries and companies have embedded design thinking within their organisation, which allows for continuous feedback and improvements to products and services

UCB Gregory Miller VP & Global Head Innovation Acceleration CoE UCB

Roundtables: Revolutionise support through digital and new tech

In an age where everyone is glued to their smartphone, and the world wide web is never more than a quick click away, patients can play a larger role in their own healthcare. So, are wearable devices, smart contact lenses and detailed mobile apps the answer to all healthcare’s issues? Maybe…but first we must create usable tools which genuinely benefit patients’ lives.

  • Visualise how new technology is empowering patients to take a more active role in monitoring their health and treatments
  • Understand how patients and HCPs envisage using digital tools and devices, ensuring your services around the pill provide real benefit and improve lives
  • Co-create new tools to ensure simple and effective user experience, and collect continuous feedback to further improve functionality and performance

ECCO – the European CanCer Organisation Birgit Beger Chief Executive Officer ECCO – the European CanCer Organisation

- Teresa Ferreiro Certified Professional Co-active Coach (CPCC) (ACC)

Shire Miguel Bernebeu Global Head of Market Access, Pricing and Health Economics Shire

Carole Sian Scrafton MBS, BA (hons) Patient Advocate

Sonia Hawkins Patient Advocate

Barcelona Children’s Hospital Begonya Nafría Patient Advocacy Manager Barcelona Children’s Hospital

MSD Sinead Tuite Patient Programmes Manager, Immunology MSD

Myeloma UK Rosemarie Finley Chief Executive Myeloma UK

Astrid Wijngaarden Patient Advocate

The Epilepsy Society Jasmine Smith Patient Ambassador The Epilepsy Society

09:30 - 10:00
Now its personal: Using machine learning to personalize your future customer centric strategy
  • As streams of customer information are rapidly expanding to ‘big data lakes’, this talk will learn you how to use these great sources to develop a deeper understanding about the individual needs and wants of customers
  • Discover how AI and machine learning can help pharma companies to maximize this data potential and support better decision making
  • Find out how a customer centric strategy can be enriched by an unrivalled personalised touch

Trilations Björn Van Loy (PhD) Competence Centre Lead Advanced Analytics Trilations

Using Machine Learning to Develop Winning Digital Channel Strategy, Execution and Analysis

IQVIA Bernd Haas Vice President, Technology Solutions IQVIA

IQVIA Agnieszka Wolk Director, Statistical Services IQVIA

10:00-10:40
Panel: Slick, seamless, yet sophisticated: delivering the ultimate customer experience
  • Envision how pharma can learn from industries who’ve created  truly integrated multichannel offering and seamlessly blend user experience across all channels
  • Equip different departments to begin the CX transition and ensure the required capabilities are in place to optimise mobile and digital channels
  • Tailor your marketing strategy to ensure alignment between various platforms to ensure a seamless, consistent and effortless user experience

Biogen Tommy Kok Annfeldt Senior Manager Digital 3rd Party Media and Innovation EU and Canada Biogen

Grünenthal Group Florent Edouard SVP, Global Head of Commercial Excellence and Customer Engagement Grünenthal Group

TEVA Davidek Herron Head of Human Channels, Customer Experience TEVA

Panel: The evolving needs of the digital native customer
  • Hear directly from patients and caregivers to identify their needs and tailor future communication
  • Remove the guesswork: build a comprehensive understanding of how to communicate with your customers, tailor your content and ensure consistent messaging across channels
  • Identify opportunities to support HCP-patient relationships, improving outcomes and cementing your company as a trusted partner

Pharmaceuticals ALK Mads Lacoppidan General Manager & Head of Consumer Division Pharmaceuticals ALK

- Teresa Ferreiro Certified Professional Co-active Coach (CPCC) (ACC)

TEVA Mark Milton Edwards Global Commercial Senior Director TEVA

SERMAS - Madrilenian Health Service Javier Rodríguez Hernández Medical Director Hospital La Fuenfría SERMAS-Madrilenian Health Service

Session announced next week

Merck Steven Hildemann Global Chief Medical Officer Merck

10:40 - 11:10
Coffee Break & Networking Sessions
11:10 - 11:40
Reinvent your go-to-market model: the integrated multichannel approach
  • Discover how Pfizer Oncology recently delivered a series successful product launches by evolving their go-to market approach
  • Evolve the traditional sales force model to deliver an improved integrated multichannel experience, utilising new digital channels and capabilities
  • Identify key markets to develop pilots and tailor to successfully role out across your whole organisation

Pfizer Markus Kosch Vice President Oncology Portfolio, Europe, Japan & Developed Asia Pfizer

Innovation for a bright future- Time to deliver genuine results from innovation and tech
  • Create a shift in the mindset of your commercial teams which encourages adaption of new ways of working and future-proofs your organisation
  • Ensure innovation strategy is a fusion of the best and brightest in science and technology
  • Case Study: Understand how Merck Biopharma is leading the future with the Innovation Cup – Cross-generational innovation to cover unmet medical need

Merck Biopharma Ulrich Betz Vice President Innovation Merck Biopharma

How R&D at Grünenthal is being shaped by listening to patients with chronic pain conditions

Grünenthal Group Lars Joensson Lead Patient Engagement Grünenthal Group

11:40 - 12:10
Artificial Irrelevance: Do physicians actually care about Healthcare’s AI Revolution?
  • “Artificial Intelligence” is the biggest buzzword in our industry, just like “Wearables” and “Mobile Apps” before it. How do we separate the fluff from meaningful new opportunities in physician engagement?
  • In this talk, Medscape’s VP of Product Design and Innovation takes a close look at global physician attitudes and behaviours to help marketers form innovative strategies for effective program design

Medscape/Web MD Ben Greenberg Vice President of Product and User Experience WebMD/ Medscape

Session announced next week
People versus study subjects and data points: Why we need to rethink patient engagement across the clinical development and commercial lifecycle

IQVIA John Procter Head of Global Service & Solution Development Patient Engagement & Medical Affairs IQVIA

12:10 - 13:15
Workshop Sessions

The workshops are for pharma & biotech companies only. Coffee and snacks will be served in the expo hall at this time


13:15 - 14:15
Lunch & Networking Session
Advances in Customer Engagement Track
Commercial Model Innovation Track
Patient Innovation Track
14:15 - 14:20
Chairman Opening

Bionical Bionical

Chairman Opening

Eagle Productivity Solutions Eagle Productivity Solutions

Chairman Opening

Bionical Bionical

14:20 - 14:50
Patients as your most insightful colleague
  • Learn from the experts - move past the lip-service and instil genuine patient insight into your business planning
  • Ensure your brand differentiates itself in a crowded market by guaranteeing your product offerings deliver real benefit to patients
  • Set up regular touch points with end users to ensure you don’t lose sight of initial goals and traditional working methods do not prevent genuine breakthroughs

Pfizer Nolan Townsend Regional President, International Developed Markets Pfizer

Generate competitive advantages through creative commercialisation strategies: lessons learned from oncology biosimilars
  • Identify innovative ways to market your product and portfolio in a highly competitive biosimilar market
  • Leveraging learnings from the Oncology Biosimilar market to successful commercialization approaches within the oncology innovator landscape
  • Build a creative CX strategy which truly addresses customer needs and promotes a patient-centric culture within your organization

Boehringer Ingelheim Georgina Rizik Global Commercial Head (Team Leader) of Oncology Biosimilars Franchise Boehringer Ingelheim

Case Study: TEVA Connected Respiratory (incl. CareTRx), on simplifying chronic respiratory diseases management
  • Find out how TEVA is revolutionising chronic respiratory disease management through automatic tracking and adherence tools
  • Listen to how personalised feedback can help patients gain better insight into their condition and achieve their goals
  • The aim: to empower patients to take a more active role in their treatment.

TEVA Pharmaceuticals Mark Milton-Edwards Global Commercial Senior Director TEVA

14:50 - 15:20
Address the biggest challenges in the global HCP community - 4 doctors, 4 countries, 4 specialties
  • Discover key insight from doctors from across a range of locations and specialties
  • Identify biggest challenges currently facing HCPs and how pharma can provide holistic solutions
  • How pharma can utilise digital to improve communication and outcomes for doctors and patients

M3 Paul Rice Chief Operating Officer M3

Cambridge University Hospitals NHSFT Dr Deepak Jadon Consultant Rheumatologist & Director of the Rheumatology Research Unit Cambridge University Hospitals NHSFT

Dr Michael Bangemann HCP

From engagement to outcomes – delivering value with patient programs
  • Understand the key elements of patient engagement strategies that drive both health and business outcomes
  • Realise the balance of technology vs. human elements in patient engagement programs, and how this is driving new opportunities and more successful programs
  • Discover unique insights from a “how-to” story around a real-world example of patient engagement that drives outcomes while enabling automation and scale

PEGA Ed Chase Senior Director, Life Sciences Strategy PEGA

Roundtables: Creating a truly effective patient support program

We all know that advances in digital technology are providing seemingly infinite opportunities to enhance healthcare for patients, but how can we create truly effective solutions? As with most things, it’s critical to start with the end user in mind -- in this instance, the patient. In this interactive session, we’ll explore the building blocks of a successful patient support program, including how to:

  • Use a value proposition framework as a model to identify patient and stakeholder challenges
  • Overcome key challenges that have the greatest impact on health outcomes
  • Discover how to use a MVP (minimum viable product) approach to digital health program development

ECCO – the European CanCer Organisation Birgit Beger Chief Executive Officer ECCO – the European CanCer Organisation

- Teresa Ferreiro Certified Professional Co-active Coach (CPCC) (ACC)

Shire Miguel Bernebeu Global Head of Market Access, Pricing and Health Economics Shire

Carole Sian Scrafton MBS, BA (hons) Patient Advocate

Barcelona Children’s Hospital Joana Claverol Clinical Research Unit Manager Barcelona Children’s Hospital

TEVA Ana Maria Arboleda Director Operations Patient Services Europe TEVA

TEVA Ruth Wilson Global Head of Patient Advocacy TEVA

SERMAS-Madrilenian Health Service Javier Rodríguez Hernández Medical Director Hospital La Fuenfría SERMAS-Madrilenian Health Service

The Epilepsy Society Jasmine Smith Patient Ambassador The Epilepsy Society

15:20 - 15:50
Get personal with a complete 360-degree view of your customer
  • Coordinate a seamless customer experience by delivering complete visibility of all customer interactions across your commercial teams
  • Identify customer trends, learn what works and create a personalised engagement strategy through analysing integrated CRM data across all platforms
  • Understand why even where we purse customer centricity, pharma is not being recognised for being so.
  • Optimise marketing spend by removing wasteful campaigns and engage with customers on their terms

Roche Rafael Ramon Commercial Excellence Leader EEMEA Roche

Session announced next week
15:50 - 16:20
Coffee Break & Networking Sessions
16:20 - 16:50
Measuring pharma performance of the practical application of Lean & Six Sigma methodology: The way to the Customer Engagement

Alfasigma Domenico Zilioli Commercial Director, Spanish Headquarters Alfasigma

Tackle complexity in healthcare head-on: KAM and MSL coordination, Daiichi Sankyo’s ‘Account Engine Model’
  • Create a deeper understanding of your customer network by transitioning to a Key Account Management (KAM) approach
  • Key Account Management (KAM) vs Key Account Organisation (KAO) – evolution of your operating model
  • ‘The Account Engine Model’: Learn how Daiichi Sankyo has developed a new and innovative KAM approach across the territory account teams
  • Develop trusted partnerships which ensure long-term commercial success by addressing needs of prescribers, policy makers, patients and payers
  • Coordinate medical and sales teams to support customers with precise medical information while providing a harmonious customer experience

Daiichi Sankyo Oncology Europe Patrik Grandits Head of Commercial Operations Oncology Europe Daiichi Sankyo Oncology Europe

Social Media 2.0 – empowering patients and families in the management of rare disease
  • Envision how social media can be a powerful tool for educating and supporting, effectively sidestepping geographical and language barriers
  • Develop a user friendly platform with allows for interaction from patients, caregivers, and healthcare professionals
  • See how social media can be used to collect consensual clinical smart data, vastly improving knowledge of disease history, diagnosis, complications and management

Barcelona Children’s Hospital Begonya Nafría Patient Advocacy Manager Barcelona Children’s Hospital

Barcelona Children’s Hospital Joana Claverol Clinical Research Unit Manager Barcelona Children’s Hospital

16:50 - 17:20
Changing the game in customer engagement: New strategies for connection, intelligence and orchestration

IQVIA Kris Bruynseels Senior Principal, Technology Solutions IQVIA

IQVIA Siva Nadarajah General Manager, Social IQVIA

Guarantee success through digital relationship marketing
  • Reignite the relationship: discover why the relationship building is a critical ingredient in effective digital communication
  • Discover how you can effectively access HCPs through digital channels and leverage your existing relationships
  • Improve every aspect of your operations using cutting-edge digital relationship marketing

Connectmedica Michal Komorniczak Global Sales Director Connectmedica

Connectmedica Igor Gnot Partner & CEO Connectmedica

Roundtables: Creating personalised and engaging patient support programs

A new generation of patient support programs are completely reinventing the way patients manage their treatment and engage with pharma. Personalising your value beyond the pill offering as well as recognising unmet needs can help you provide real value to patients. So with so many companies providing these services how can you identify the best place to invest recourses?

  • Personalise individual support programs by carefully tailoring channels, message content and frequency of interactions
  • Combine patient feedback with data to support decision making, clear obstacles and make your patient-focussed decisions more reliable
  • Define metrics which determines success of program, captures both patient and HCP-related outcomes and provides insights to further improve support

ECCO – the European CanCer Organisation Birgit Beger Chief Executive Officer ECCO – the European CanCer Organisation

- Teresa Ferreiro Certified Professional Co-active Coach (CPCC) (ACC)

Shire Miguel Bernebeu Global Head of Market Access, Pricing and Health Economics Shire

17:20 - 17:50
Speak with one voice as an integrated commercial outfit
  • Drive commercial results with full visibility of customer interactions to optimise face-to-face visits
  • Encourage collaboration between marketing and sales departments to allow reps to react to changing preferences in real time
  • Relay customer insights, based on the rep’s knowledge, to personalise future marketing campaigns and tailor outreach

UCB Arnaud Lefevre Head of Operations, Northern Europe UCB

The Biotech revolution in Rare and Orphan diseases? Meet the pioneering companies defining a new commercial model for Pharma
  • Hear about the challenges in terms of market access and reimbursement when payors and regulators are operating in an increasingly cost constrained health system.
  • Understand how these companies; inevitably develop closer, more authentic relationships with patients and why that creates a whole new sense of purpose.
  • Understand the risks and rewards of being part of this Biotech European commercialization revolution.

Moderator: Morgan Prestwich Sean Morgan-Jones VP Global BD Morgan Prestwich

Kyowa Kirin Adrian Steventon-Hill Global Franchise Head Kyowa Kirin

Vertex Pharma Simon Lem VP and General Manager Northern Europe Vertex Pharma

PTC Therapeutics Adrian Haigh SVP & GM EMEA & Asia Pac PTC Therapeutics

Alnylam Pharma Anant Murthy VP Market Access & Policy EU & Canada Alnylam Pharma

17:50 - 19:30
Networking Drinks Reception

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!

Closing Keynote
08:55 - 09:00
Chairman Opening

eyeforpharma Paul Simms Chairman eyeforpharma

09:00 - 09:25
Paving the way for the next generation of fully integrated care
  • Beyond medicine: Develop solutions that can deliver value and real benefits to patients' lives throughout the care continuum
  • Explore partnerships needed to provide holistic care and further support patients: the role that the industry can play
  • Understand the potential of digital in the development of future healthcare models and further possibilities on the horizon

Takeda Giles Platford President, Europe and Canada Business Unit Takeda

09:25 - 09:50
Paradigm shift: From selling drugs to bringing solutions to patients

AstraZeneca Bahija Jallal EVP & Head Medimmune AstraZeneca

09:50 - 10:20
From surviving to thriving: 4 steps to business optimisation
  • Understand why your sales department is the most critical tool for your future positioning and reputation
  • Examine four critical ways to prepare your sales organization for the future.
  • Uncover how to address the disruption in business to fix your sales organization before it’s too late.
  • Identify immediate steps required to improve your performance long-term

Miller Heiman Group Byron Matthews President and CEO Miller Heiman Group

10:20 - 10:30
Winner announced for the eyeforpharma Awards – Most Valuable HCP Initiative
10:30 - 11:10
Panel: The next step in truly integrated healthcare
  • The role of pharma in changing the delivery of healthcare and the partnerships required to solve genuine healthcare challenges
  • Develop a better understanding of the life and treatment with disease to deliver a seamless heathcare solution
  • How the digital revolution and information sharing will develop holistic intergrated care models

Novartis Shreeram Aradhye Chief Medical Officer, Global Head of Medical Affairs Novartis

UICC (Union for International Cancer Control) Dr. Cary Adams CEO UICC (Union for International Cancer Control)

Sanofi Colin Sims SVP, Head, Transversal Corporate Strategy Sanofi

11:10 - 11:40
Coffee Break & Networking Session in the Exhibition Hall
11:40 - 12:05
Session to be announced

Microsoft Microsoft

12:05 - 12:45
Digital Panel: Harness the true power of digital to perform strategic transformations that deliver genuine healthcare innovation
  • The role of digital in improving patient outcomes and commercial results
  • Ensure uptake of digital practices across the entire organisation and embed your digital strategy into the culture
  • The role digital innovations will play in the future of healthcare and how we can get there

Sanofi Milind Kamkolkar Chief Data Officer Sanofi

AstraZeneca Bahija Jallal EVP & Head of Medimmune AstraZeneca

Roche Diabetes Care Jacob Suñol Digital CTO & Digital Ecosystem Roche Diabetes Care

12:45 - 13:00
Winner announced eyeforpharma Awards - Most Valuable Collaboration
13:00 - 13:20
Keynote Address

Almirall Alfredo Barón de Juan EVP Global Commercial Operations Almirall

13:20 - 14:40
Seated Lunch & Networking Session on the 2nd Floor

DISCOVER MORE – DOWNLOAD THE FULL EVENT BROCHURE

Full Agenda | Speaker faculty | Group Discounts